Supermax Drugs & Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 3.00 M
- Company Age 30 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 17.24 Cr
- Satisfied Charges ₹ 8.40 M
- Revenue Growth 142.92%
- Profit Growth 153.63%
- Ebitda 53.05%
- Net Worth 100.23%
- Total Assets 54.20%
About Supermax Drugs & Pharmaceuticals
Supermax Drugs & Pharmaceuticals Private Limited (SDPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 25 April 1994 and has a history of 30 years and nine months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹17.24 Cr. The company has closed loans amounting to ₹8.40 M, as per Ministry of Corporate Affairs (MCA) records.
Thakar Bhatia, Saurabh Bhatia, Aloke Ghosh, and One other member serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74899DL1994PTC058598
-
Company No.
058598
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Apr 1994
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Supermax Drugs & Pharmaceuticals Private Limited offer?
Supermax Drugs & Pharmaceuticals Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs.
Who are the key members and board of directors at Supermax Drugs & Pharmaceuticals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thakar Bhatia
|
Director | 25-Apr-1994 | Current |
|
Saurabh Bhatia
|
Director | 10-Apr-2019 | Current |
|
Aloke Ghosh
|
Director | 11-Dec-2019 | Current |
|
Chetan Bhatia
|
Director | 10-Apr-2019 | Current |
Financial Performance of Supermax Drugs & Pharmaceuticals.
Supermax Drugs & Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 142.92% increase. The company also saw a substantial improvement in profitability, with a 153.63% increase in profit. The company's net worth Soared by an impressive increase of 100.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Supermax Drugs & Pharmaceuticals?
In 2022, Supermax Drugs & Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹17.24 Cr
₹0.84 Cr
Charges Breakdown by Lending Institutions
- Others : 16.82 Cr
- Tata Capital Financial Services Limited : 0.42 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Nov 2023 | Tata Capital Financial Services Limited | ₹1.31 M | Open |
| 28 Dec 2022 | Tata Capital Financial Services Limited | ₹2.90 M | Open |
| 13 Jul 2020 | Others | ₹8.20 M | Open |
| 21 Nov 2019 | Others | ₹16.00 Cr | Open |
| 23 Jun 2015 | Central Bank Of India | ₹8.40 M | Satisfied |
How Many Employees Work at Supermax Drugs & Pharmaceuticals?
Supermax Drugs & Pharmaceuticals has a workforce of 121 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Supermax Drugs & Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Supermax Drugs & Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
